Anti-TNFRSF7/CD27 Antibody (Varlilumab)
Catalog No.
F1068
Anti-TNFRSF7/CD27 Antibody (Varlilumab)
Featured Products
Varlilumab (anti-CD27) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has anti-tumor activity.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1393344-72-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
1F5, CDX-1127
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P26842
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD27 FC at 2 ug/mL can bind Anti-TNFRSF7/CD27 Antibody (Varlilumab)
TNFRSF7 / CD27
Please avoid freeze-thaw cycles.